Organon, Kenilworth, New Jersey

Organon Completes Acquisition of Alydia Health

Merck spinoff builds up Women’s Healthcare assets

John G. Baresky

Alydia Health, Menlo Park, California
Alydia Health, Menlo Park, California

Alydia’s Jada System flagship medical device product

Alydias Jada® System is designed to promote normal contraction of the uterus and stop excessive bleeding following childbirth. In 2020 the Jada System received 510(k) clearance from the U.S. Food and Drug Administration.

  • Uterine artery ligation/embolization of the vessel
  • Obstetric gauze or device tamponade of uterus or vagina
  • Hysterectomy

Organon is just starting out as a standalone company

June 3rd, 2021 was the first official day of Organon operating fully independently from Merck. Organon is headquartered in Jersey City, New Jersey. Merck provided funding to Organon in March of 2021 to facilitate the acquisition of Alydia.

  • Older legacy products
  • Women’s Healthcare

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences